2001
DOI: 10.1006/gyno.2001.6221
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitory Effects of 17β-Estradiol and Progesterone on Ovarian Carcinoma Cell Proliferation: A Potential Role for Inducible Nitric Oxide Synthase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
29
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(32 citation statements)
references
References 30 publications
2
29
0
Order By: Relevance
“…The reports that Pg induces apoptosis in malignant mesothelioma cells 40 as well as in normal breast cells and various cancer cell lines 41 further support this view. Furthermore, in agreement with the results presented here, the role of Pg in the induction of apoptosis via induction of NOSII to increase NO levels was shown in ovarian cancer cells, 30 indicating a general function of Pg in this mechanism. In fact, several randomised studies and clinical trials have shown that treatment with progestogens led to significant though modest improvement of the relapse-free survival, 42,43 and that inclusion of progestogens in hormone replacement therapy reduces the risk of recurrence, which is associated with an increase in the apoptosis/proliferation ratio within the tumour.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…The reports that Pg induces apoptosis in malignant mesothelioma cells 40 as well as in normal breast cells and various cancer cell lines 41 further support this view. Furthermore, in agreement with the results presented here, the role of Pg in the induction of apoptosis via induction of NOSII to increase NO levels was shown in ovarian cancer cells, 30 indicating a general function of Pg in this mechanism. In fact, several randomised studies and clinical trials have shown that treatment with progestogens led to significant though modest improvement of the relapse-free survival, 42,43 and that inclusion of progestogens in hormone replacement therapy reduces the risk of recurrence, which is associated with an increase in the apoptosis/proliferation ratio within the tumour.…”
Section: Discussionsupporting
confidence: 91%
“…Previous studies have reported that both Pg and E2 alone induce NOSII expression in different cell types in the uterus 29 and that Pg stimulates NOSII expression and NO production in ovarian cancer cells. 30 In contrast, other studies showed an inhibitory effect of Pg. Thus, Pg inhibited NOSII expression in murine macrophages, 31 as well as in human colon enterocytes DLD-1 and Caco-2.…”
Section: Discussionmentioning
confidence: 88%
“…Previous studies suggest that SKOV-3 cells are growth-resistant to estradiol [57,58]. It has been suggested that over-expression of HER-2/neu and cathepsin D in SKOV-3 cells interferes with the mitogenic pathways, resulting in unresponsiveness of SKOV-3 cells to estradiol [57].…”
Section: Discussionmentioning
confidence: 98%
“…This may in part explain the decrease in PGRMC1 mRNA levels after stimulation of SKOV-3 cells with P4. A P4 concentration of 1000 nM is physiological in the ovary, in which even higher concentrations of P4 are present (37). The smaller effects on the PGRMC1 mRNA levels compared to effects on the let-7i levels (20% for PGRMC1 to 40% for let-7i) can be explained by the fact that let-7i also targets many other mRNAs.…”
Section: Discussionmentioning
confidence: 99%